🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 30233G209 (prev. 30233G100 )
- Market Cap
- Large Cap
- Previous Symbol
- PSVD (changed 4/2/2018)
- Previous Name
- pSivida Corp.
Business: pSivida Corp. is a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products in indications with high unmet medical need to help improve the lives of patients with serious eye disorders.
Notes: Dec. 08, 2020 -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced that it will effect a 1-for-10 reverse stock split at 5:00 p.m. Eastern Time today. Beginning with the opening of trading on December 9, 2020, EyePoint's common stock will trade on the Nasdaq Global Market on a split-adjusted basis under a new CUSIP number 30233G209.
Company Contact
- CEO
- Jay S. Duker
- CFO
- George O. Elston
- Headquarters
- 480 Pleasant Street, Watertown, MA 02472
- Phone
- 617-926-5000
- Fax
- 617-926-5050
- Investor Relations
- Christina Tartaglia, Stern IR · 212-698-8700 · christina.tartaglia@sternir.com